tiprankstipranks
Relay Therapeutics Inc (RLAY)
NASDAQ:RLAY
US Market
RLAY
Relay Therapeutics
RESEARCH TOOLSreports
Want to see RLAY full AI Analyst Report?

Relay Therapeutics (RLAY) Income Statement

571 Followers

Relay Therapeutics Income Statement

Last quarter (Q4 2025), Relay Therapeutics's total revenue was $7.00M, an increase of Infinity% from the same quarter last year. In Q4, Relay Therapeutics's net income was $-54.89M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 15.36M$ 10.01M$ 25.55M$ 1.38M$ 3.03M
Gross Profit
$ 11.80M$ 10.01M$ 25.55M$ 1.38M$ 3.03M
Operating Expenses
$ 314.54M$ 382.48M$ 398.55M$ 300.66M$ 367.73M
Depreciation and Amortization
$ 3.56M$ 5.46M$ 5.27M$ 4.13M$ 3.92M
EBITDA
$ -272.92M$ -380.21M$ -374.15M$ -306.82M$ -223.08M
Operating Income
$ -302.74M$ -372.47M$ -373.00M$ -299.27M$ -364.70M
Other Income/Expenses
$ 26.26M$ 34.76M$ 31.03M$ 8.77M$ 826.00K
Pretax Income
$ -276.48M$ -337.71M$ -341.97M$ -290.51M$ -363.87M
Net Income
$ -276.48M$ -337.71M$ -341.97M$ -290.51M$ -363.87M
Per Share Metrics
Basic EPS
$ -1.61$ -2.36$ -2.79$ -2.59$ -3.82
Diluted EPS
$ -1.61$ -2.36$ -2.79$ -2.59$ -3.82
Weighted Average Shares Outstanding
 171.59M 142.87M 122.58M 112.23M 95.14M
Weighted Average Shares Outstanding (Diluted)
 171.59M 142.87M 122.58M 112.23M 95.14M
Currency in USD

Relay Therapeutics Earnings and Revenue History